Certified by Founder Lodge
HI-Bio
United States - South San Francisco, California
START UP
1 Disclosed Funding Rounds $95,000,000
0 Participating Investments
-
Founded date
2021
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Human Immunology Biosciences (HI-Bio) is leading clinical immunology into its next chapter with therapies that target cellular drivers of disease. HI-Bio uses a precision medicine approach to
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| January, 05 ,2024 | Series B | $95,000,000 |
Alpha Wave Global, LP
ARCH Venture Partners
Viking Global Investors
Arkin Holdings
JEITO
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
Sizable Energy | $8,000,000 | (Oct 24, 2025)
Sumble | $38,500,000 | (Oct 24, 2025)
Syntracts | $5,300,000 | (Oct 24, 2025)
Cybrid | $10,000,000 | (Oct 24, 2025)
Elevara Medicines | $70,000,000 | (Oct 24, 2025)
